JeanneMSchilderMD

Obstetrics & Gynecology • Indianapolis, IN

Gynecologic Oncology

Mary Fendrich Hulman Professor and Chair of Gynecologic Oncology, Indiana University

Join to view full profile

Dr. Schilder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schilder's full profile

Already have an account?

Office
535 Barnhill Dr.
434
Indianapolis, IN 46202
Phone+1 317-944-7241

Fax+1 317-944-4878

Education & Training

Indiana University School of MedicineResidency, Obstetrics and Gynecology, 1993 - 1997
The University of Toledo College of MedicineClass of 1993

Certifications & Licensure

IN State Medical License 1997 - 2025
KY State Medical License 1999 - 2003
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Indianapolis Monthly Castle Connolly, 2009-2011, 2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1N...
Premal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, Jonathan Lim, John Hartman
International Journal of Gynecological Cancer. 2024-12-02
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe.
Kathleen N Moore, Mansoor R Mirza, Charlie Gourley, Sandro Pignata, Domenica Lorusso
International Journal of Gynecological Cancer. 2024-11-04
Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study.
Bobbie Rimel, Tirza Areli Calderón Boyle, Sara Burns, Jonathan Lim, John Hartman
Oncology and Therapy. 2024-09-01

Press Mentions

Stigma Attached, but Cervical Cancer Is PreventableFebruary 11th, 2018

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow